Screener
Integra LifeSciences IART Total Revenue
Total Revenue at other companies
Segments
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Integra LifeSciences’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:03 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000917520-26-000058
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Total revenue, net | $418,761 | $415,605 | $810,679 | $798,258 |
| Costs and expenses: | ||||
| Cost of goods sold | 199,017 | 206,273 | 373,953 | 394,494 |
| Research and development | 24,253 | 26,997 | 47,754 | 51,725 |
| Selling, general and administrative | 172,436 | 179,890 | 350,671 | 361,387 |
| Intangible asset amortization | 3,770 | 3,754 | 7,546 | 7,458 |
| Goodwill impairment charge | — | 511,365 | — | 511,365 |
| Total costs and expenses | 399,476 | 928,279 | 779,924 | 1,326,429 |
Item 1. Financial Statements
FAQ
- What is Integra LifeSciences's total revenue?
- Integra LifeSciences (IART) reported total revenue of $418.76M in Q2 2026.
- How has Integra LifeSciences's total revenue changed year-over-year?
- Integra LifeSciences's total revenue increased by 0.8% year-over-year, from $415.61M to $418.76M.
- What is the long-term trend for Integra LifeSciences's total revenue?
- Over 4 years (2021 to 2025), Integra LifeSciences's total revenue has grown at a 1.5% compound annual growth rate (CAGR), from $1.54B to $1.64B.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Integra LifeSciences's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude